HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Salivary Gland Diseases (Salivary Gland Disease)

Subscribe to New Research on Salivary Gland Diseases

Also Known As:

Salivary Gland Disease; Disease, Salivary Gland; Diseases, Salivary Gland; Gland Disease, Salivary; Gland Diseases, Salivary

Networked: 58 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Stomatognathic Diseases: 372
- Mouth Diseases: 60
  - Salivary Gland Diseases: 58

Related Diseases

1.	Wounds and Injuries (Trauma)
2.	Neoplasms (Cancer)
3.	Acquired Immunodeficiency Syndrome (AIDS)
4.	Vascular Malformations
5.	Hyperamylasemia

Experts

1.	Bozzato, A: 2 articles (06/2015 - 05/2009)
2.	Greenspan, D: 2 articles (05/2001 - 06/2000)
3.	Whitney, Eli M: 1 article (09/2015)
4.	Treister, Nathaniel S: 1 article (09/2015)
5.	Stoopler, Eric: 1 article (09/2015)
6.	DeRossi, Scott S: 1 article (09/2015)
7.	Brennan, Michael T: 1 article (09/2015)
8.	Singh, Harsharan K: 1 article (06/2015)
9.	Nickeleit, Volker: 1 article (06/2015)
10.	Xi, Hong: 1 article (03/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Salivary Gland Diseases:

1.	Immunoglobulin G (IgG)IBA 10/01/2009 - "The median serum IgG4 level was significantly greater in Mikulicz's disease (357.0mg/dl) than in other salivary gland diseases (p<0.01). " 10/01/2009 - "Of 75 patients with elevated serum IgG4 levels, 15 had diseases other than pancreatobiliary and salivary gland diseases. "
2.	alfuzosin (UroXatral)FDA Link 06/01/2010 - "A significant improvement of symptoms was observed in patients treated with Alfuzosin for obstructive salivary gland diseases. " 06/01/2010 - "[Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases]."
3.	ParaffinIBA 08/01/1991 - "In the group of patients with salivary gland diseases, none produced measurable amounts of resting saliva but a few of them did produce small amounts of paraffin wax chewing-stimulated saliva. " 01/01/1999 - "Formalin-fixed, paraffin embedded tissue sections of 87 cases of salivary gland diseases were used for the study of EBV with PCR, in situ PCR for EBNA-1 (EBV nuclear antigen-1), and immunohistochemistry for LMP-1 (latent membrane protein-1). "
4.	AntigensIBA 03/01/1968 - "[Application of the method of fluorescent antibodies for cellular localization of salivary gland antigens in chronic salivary gland diseases]." 01/01/1999 - "Formalin-fixed, paraffin embedded tissue sections of 87 cases of salivary gland diseases were used for the study of EBV with PCR, in situ PCR for EBNA-1 (EBV nuclear antigen-1), and immunohistochemistry for LMP-1 (latent membrane protein-1). "
5.	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/01/1994 - "In the present study, calprotectin levels in plasma and whole saliva were analysed and evaluated as potential markers of SS and salivary gland disease activity. "
6.	Dental Implants (Dental Implant)IBA 01/01/1996 - "CT has also been used to study salivary gland disease, injuries of the facial skeleton, and dental implant treatment planning. "
7.	Membrane Proteins (Integral Membrane Proteins)IBA 01/01/1999 - "Formalin-fixed, paraffin embedded tissue sections of 87 cases of salivary gland diseases were used for the study of EBV with PCR, in situ PCR for EBNA-1 (EBV nuclear antigen-1), and immunohistochemistry for LMP-1 (latent membrane protein-1). "
8.	Formaldehyde (Formol)FDA Link 01/01/1999 - "Formalin-fixed, paraffin embedded tissue sections of 87 cases of salivary gland diseases were used for the study of EBV with PCR, in situ PCR for EBNA-1 (EBV nuclear antigen-1), and immunohistochemistry for LMP-1 (latent membrane protein-1). "
9.	EBV-encoded nuclear antigen 1IBA 01/01/1999 - "Formalin-fixed, paraffin embedded tissue sections of 87 cases of salivary gland diseases were used for the study of EBV with PCR, in situ PCR for EBNA-1 (EBV nuclear antigen-1), and immunohistochemistry for LMP-1 (latent membrane protein-1). "
10.	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 07/01/1989 - "Technetium-99m pertechnetate and gallium-67 imaging in salivary gland disease." 01/01/1976 - "[Diagnostic value of sodium pertechnetate in salivary gland diseases]." 03/01/2015 - "Technetium 99m pertechnetate salivary gland scintigraphy played a substantial role in the diagnosis and differential diagnosis of salivary gland diseases." 03/01/2015 - "To evaluate the diagnostic value of technetium 99m pertechnetate salivary gland scintigraphy in patients with certain salivary gland diseases. " 03/01/2015 - "The diagnostic value of technetium 99m pertechnetate salivary gland scintigraphy in patients with certain salivary gland diseases."

Therapies and Procedures

1.	Sclerotherapy 04/01/2009 - "The aim of the study was to determine the effectiveness of alcohol sclerotherapy in patients with human immunodeficiency virus related salivary gland disease. "
2.	Oral Medicine 03/01/2005 - "2003 at the Department of salivary gland diseases, School of Stomatology, Wuhan University, including 19 parotid cases (27 sides) and 6 submandibular gland cases (7 sides); 16 females and 9 males. " 03/24/1990 - "Oral medicine in practice: salivary gland disease." 09/01/2015 - "Oral Medicine is primarily a nonsurgical dental discipline that includes management of (1) oral mucosal and salivary gland diseases; (2) temporomandibular disorders and orofacial pain; (3) oral complications of systemic disease; and (4) dental management of medically complex patients within its scope of practice. "
3.	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 06/01/2015 - "sialendoscopy, lithotripsy, therapeutic duct lavage and extracapsular dissection) for salivary gland disease presuppose a precise imaging modality. " 05/01/2002 - "To investigate the use of shock-wave lithotripsy in the treatment of salivary gland disease in HIV-positive patients. "
4.	Immunomodulation 02/01/1987 - "Although the generally benign nature of auto-immune salivary gland disease precludes the use of many of the potentially toxic treatment regimens discussed here, the appreciation of these approaches to immunomodulation provides a basis upon which to develop new and innovative therapeutic strategies."
5.	Highly Active Antiretroviral Therapy (HAART) 05/05/2001 - "There was an increase in salivary-gland disease and a striking increase in warts: three-fold for patients on antiretroviral therapy and six-fold for those on HAART (p=0.01). "